تفصیل
A new phase 3 trial (MANEUVER) investigates pimicotinib, a highly selective CSF-1R inhibitor, for unresectable tenosynovial giant cell tumour (TGCT). Part 1 results show promising anti-tumor activity with a manageable safety profile. In this video, authors of the trial describe MANEUVER and explain what this could mean for TGCT patients. Read the full article at: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02602-9/fulltext?dgcid=youtube_video_lancet_maneuver-2026 Visit The Lancet at https://www.thelancet.com/?dgcid=youtube_video_lancet_maneuver-2026 * * * Continue this conversation on social! Follow us today at… https://TheLancet.bsky.social/ https://Facebook.com/TheLancetMedicalJournal https://Instagram.com/TheLancetGroup https://LinkedIn.com/company/The-Lancet
آپ کو یہ بھی پسند آ سکتے ہیں
- 1
البمJoro Cire
Joro Cire · 349 پلے
- 2
البمChromo Sapiens: Tónlist fyrir Shoplifter
3,411 پلے
- 3
البمAmanito
Amanito · 7,878 پلے
- 4
البمUnsteady
Unsteady · 8,026 پلے
- 5
البمOn a Cloud
Max Imo · 5,183 پلے
- 6
البمLevel Up
Krey Galin · 8,206 پلے
- 7
البمStuck in da Trap
Ososolid · 4,521 پلے
- 8
البمWOOGIE Radio
6,642 پلے
- 9
البمLynn Goldsmith and the Jeter Mountain Band
Lynn Goldsmith and the Jeter Mountain Band · 3,972 پلے
- 10
البمColaps Radio
174 پلے
- 11
البمComplete Car Tuning & Performance Guide: From Basics to Advanced Upgrades: Everything Every Car Enthusiast Needs to Know About Performance, Safety, and Style
8,366 پلے
- 12
البمSome Birds Can't Fly
Colin Adams · 4,323 پلے